Rankings
▼
Calendar
INVA FY 2025 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$425M
+18.5% YoY
Gross Profit
$308M
72.3% margin
Operating Income
$164M
38.5% margin
Net Income
$271M
63.8% margin
EPS (Diluted)
$3.30
Cash Flow
Operating Cash Flow
$197M
Free Cash Flow
$196M
Stock-Based Comp.
$9M
Balance Sheet
Total Assets
$1.6B
Total Liabilities
$462M
Stockholders' Equity
$1.2B
Cash & Equivalents
$551M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$425M
$359M
+18.5%
Gross Profit
$308M
$322M
-4.5%
Operating Income
$164M
$167M
-1.9%
Net Income
$271M
$23M
+1059.2%
← Q4 2024
All Quarters
Q1 2025 →